Search

Now showing items 1-10 of 37

Redundancy and robustness versus division of labour and specialization in innate immunity

Mantovani, A (2018-04)

Annexin A1: Uncovering the Many Talents of an Old Protein.

Sheikh, MH; Solito, E (2018-03-31)

Annexin A1 (ANXA1) has long been classed as an anti-inflammatory protein due to its control over leukocyte-mediated immune responses. However, it is now recognized that ANXA1 has widespread effects beyond the immune system ...

Smile-It's in your blood!

D'Acquisto, F; Rattazzi, L; Piras, G (2014-10-01)

ACTH: The forgotten therapy

Montero-Melendez, T (2015-05)

Old drugs with new skills: fenoprofen as an allosteric enhancer at melanocortin receptor 3

Montero-Melendez, T; Forfar, RAE; Cook, JM; Jerman, JC; Taylor, DL; Perretti, M (2017-04)

Lactate at the crossroads of metabolism, inflammation, and autoimmunity

Pucino, V; Bombardieri, M; Pitzalis, C; Mauro, C (2017-01)

Autonomic regulation of systemic inflammation in humans: A multi-center, blinded observational cohort study.

Ackland, GL; Minto, G; Clark, M; Whittle, J; Stephens, RCM; Owen, T; Prabhu, P; Del Arroyo, AG (2018-01)

OBJECTIVE: Experimental animal models demonstrate that autonomic activity regulates systemic inflammation. By contrast, human studies are limited in number and exclusively use heart rate variability (HRV) as an index of ...

The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-beta peptide

Ries, M; Loiola, R; Shah, UN; Gentleman, SM; Solito, E; Sastre, M (2016-09-02)

Shed syndecan-2 inhibits angiogenesis

De Rossi, G; Evans, AR; Kay, E; Woodfin, A; McKay, TR; Nourshargh, S; Whiteford, JR (2014-11-01)

A novel hybrid promoter responsive to pathophysiological and pharmacological regulation

Subang, MC; Fatah, R; Bright, C; Blanco, P; Berenstein, M; Wu, Y; Podhajcer, OL; Winyard, PG; Chernajovsky, Y; Gould, D (2012-04)